GlobeNewswire by notified

Auriant Mining AB (publ.) publishes Q1 2022 operational update



  • In Q1 2022, hard rock gold production amounted to 216.7 kg (6,967 oz), compared to 209.7 kg (6,743 oz) in Q1 2021, an increase of 3%, or 7 kg (224 oz);
  • Due to the seasonality of the operations at Staroverinskaya (Solcocon), there was no alluvial gold production in the period, although 47 155 m3 of top soil was moved in Q1 2022 preparing access to the gold sands;
  • In Q1 2022, total gold sales were 292.1 kg (9,392 oz), compared to 180.0 kg (5,787 oz) in 3m 2021, an increase of 112.1 kg (3,605 oz), or 62%;
  • 96,268 tonnes of ore with an average grade of 2.44 g/t were processed through the CIL plant;
  • The CIL plant operated for 1,887 hours at an increased throughput rate of 51 tonnes per working hour (>50 t/hour) and at the targeted recovery rate of 91.2%;
  • 51,090 tonnes of ore were mined in Q1 2022, compared to 26,190 tonnes in Q1 2021, an increase of 24,900 tonnes or 95%. Stripping volume amounted to 528,200 m3 (+115,600 m3, or 28% more than in Q1 2021);
  • The average grade in Q1 2022 was 2.44 g/t, compared to 2.04 g/t in Q1 2021, an increase of 20%;

Overall, Q1 2022 production was in line with the Company’s production plan.


  • In regards to the current challenging geopolitical situation, although operations at Tardan have been unaffected, the Company has decided to widen its gold sales channels.  
    • Three new sales contracts with refinery plants were signed.
    • The Company’s subsidiary has applied for an export license to be able to sell gold outside Russia.
    • There is an option of selling gold to a new bank under a new sales contract.   

Despite the current restrictions and the challenging market environment, the Company’s subsidiaries continue to sell gold, but with discounts to the LBMA gold price that can be substantial. The effect of these discounts is to some extent mitigated by the strong gold price and the weak Ruble.   

Total Gold Production

Production unit3m 20223m 2021Change
 Hard rock
    Tardan (CIL) 216.7 6,967 209.7 6,743 7.0 224 3%
Staroverinskaya - - - - - - -
 Total gold produced 216.7 6,967 209.7 6,743 7.0 224 3%

Hard Rock Gold Production

 Unit 3m 20223m 2021 Change
 Waste stripping  000 m3         528.2             412.6             115.6   28%
 Ore mined  000 tonnes             51.1               26.2               24.9   95%
 Gold in Ore  kg          134.5               63.4               71.2   112%
 Average grade  g/t            2.63               2.42               0.21   9%
 Ore processing  000 tonnes            96.3               96.2                  0.0   0%
 Grade  g/t            2.44               2.04               0.40   20%
 Gold in ore processing  kg         235.2             196.5               38.7   20%
 Gold produced CIL  kg         216.7            209.7                  7.0   3%
 Opening WIP (gold)  kg               5.2               27.9  
 Closing WIP (gold)  kg              2.9  
 Recovery  % 91.18% 92.5% -1.4% -1.5%
 Warehouse on Mar 31
 Ore  000 tonnes            86.4               31.3                55.0   176%
 Grade  g/t            2.16               2.30   -           0.14   -6%

For more information, please contact:

Danilo Lange, CEO
Tel: +7 495 109 02 82

Company name: Auriant Mining AB Short name: AUR
ISIN-code: SE0001337213


Auriant Mining AB (AUR) is a Swedish junior mining company focused on gold exploration and production in Russia, primarily in the Republic of Tyva, Zabaikalye and the Republic of Khakassia. The company has currently four assets, including two operating mines (Tardan and Alluvial at Staroverinskaya), one early stage exploration asset and one development asset.

Since July 19, 2010, Auriant Mining´s shares are traded on Nasdaq First North Premier Growth Market under the short name AUR. For more information, please visit G&W Fondkommission is Certified Adviser to Auriant, for more information please call +46 8 503 000 50, e-mail or visit

This information is information that Auriant Mining AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 15.35 CET on April 20th, 2022.


To view this piece of content from, please give your consent at the top of this page.
To view this piece of content from, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Mandalay Resources Corporation Announces the Results of Its Annual General Meeting of Shareholders25.5.2022 23:32:49 CEST | Press release

TORONTO, May 25, 2022 (GLOBE NEWSWIRE) -- Mandalay Resources Corporation ("Mandalay" or the "Company") (TSX: MND, OTCQB: MNDJF) is pleased to announce the results of its Annual General Meeting of Shareholders (the “Meeting”) held today virtually. All the resolutions presented at the Meeting were approved by the shareholders, with the votes cast by proxy representing 67.63% of the total shares outstanding as of the record date. Election of Directors The number of directors was fixed at seven members and each of the seven nominees listed in the Company’s Management Information Circular dated April 14, 2022, were re-elected to the Company’s Board of Directors. Abraham Jonker remains the lead independent director and Bradford Mills continues as Chair. Results of the votes cast by proxy are set out below. ResolutionVotes Cast by Proxy For% ForVotes Cast by Proxy Withheld% WithheldBradford A. Mills61,552,12099.95329,1930.047Abraham Jonker61,551,31399.95130,0000.049Amy Freedman61,547,53899.94

Galapagos to showcase commitment to rheumatoid arthritis care at the upcoming European League Against Rheumatism congress25.5.2022 22:01:00 CEST | Press release

Celebrating EULAR’s 75thanniversary with focus on a new era of rheumatoid arthritis care Mechelen, Belgium;25 May 2022, 22.01CET;Galapagos NV (Euronext & Nasdaq: GLPG) will present 11 abstracts at the European League Against Rheumatism (EULAR) congress 2022, 01-04 June, taking place in Copenhagen, Denmark. The broad range of abstracts include trial data analyses supporting the efficacy and safety profile of filgotinib andreal-world clinical data around alignment of prescribing between physicians and rheumatoid arthritis (RA) patients. Galapagos is also hosting a hybrid symposium: “Evolving patient care in RA: Can JAK inhibitors meet patient and physician expectations for RA treatment?”, which will include a discussion focused on aligning physician and patient treatment goals, looking at what is meant by ‘comprehensive care’ and how to ensure that people living with RA are part of treatment and care goal setting. A meet-the-expert session, “Patient-centred care in RA: cutting through th

trivago N.V. Announces Annual General Meeting of Shareholders25.5.2022 21:39:06 CEST | Press release

trivago N.V. (NASDAQ: TRVG) announced today that its annual general meeting of shareholders will be held on June 30, 2022 at the offices of NautaDutilh N.V., Beethovenstraat 400, 1082 PR Amsterdam, the Netherlands. The meeting will start at 3:00 p.m. CEST. The convening notice and explanatory notes for the general meeting are available free of charge in the Investor Relations section of trivago N.V.'s corporate website at About trivago N.V. trivago is a leading global hotel search platform focused on reshaping the way travelers search for and compare hotels and alternative accommodations. Incorporated in 2005 in Düsseldorf, Germany, the platform allows travelers to make informed decisions by personalizing their hotel search and providing them access to a deep supply of hotel information and prices. trivago enables its advertisers to grow their businesses by providing access to a broad audience of travelers via its websites and apps. As of March 31, 2022, trivago has est

Correction: Changes in Nokia Corporation's own shares25.5.2022 19:20:00 CEST | Press release

Nokia Corporation Stock Exchange Release 25 May 2022 at 20:20 EEST Correction: Changes in Nokia Corporation's own shares Espoo, Finland – This is a correction to "Changes in Nokia Corporation's own shares" stock exchange release that was published today at 19:30 EEST. A total of 183 965 Nokia shares (NOKIA) held by the company were today transferred without consideration to participants of Nokia's equity-based incentive plans in accordance with the rules of the plans. The transfer is based on the resolution of the Board of Directors to issue shares held by the company to settle its commitments to participants of the plans as announced on 3 February 2022. The number of own shares held by Nokia Corporation following the transfer is 61 262 561. This version is otherwise identical but now includes an updated total number of Nokia shares transferred (incorrect number was 188 636). About Nokia At Nokia, we create technology that helps the world act together. As a trusted partner for critical

Ultimovacs’ Clinical Data in Journal for ImmunoTherapy of Cancer Show Long-term Dynamic T Cell Responses with UV1 and Checkpoint Inhibitor Synergy25.5.2022 18:45:00 CEST | Press release

Data from three trials of UV1 show dynamic T cell responses, lasting up to 7.5 years UV1-specific immune responses associated with longer clinical survivalSynergy between UV1 vaccination and checkpoint inhibition Oslo, 25 May2022: Ultimovacs ASA ("Ultimovacs") (OSE ULTI), a clinical stage leader in immune stimulatory vaccines for cancer, announced the publication of long-term follow-up data on UV1 in the Journal for ImmunoTherapy of Cancer (JITC). The data show that dynamic UV1 specific immune responses last up to 7.5 years, are associated with longer survival and are enhanced when UV1 is used in combinations with checkpoint inhibitors. “It is important to be able to share this validating data with our research and clinical colleagues through JITC. The data demonstrate highly durable UV1-induced immune responses that are associated with substantially longer overall survival and boosted by checkpoint inhibitors. This is strong support for Ultimovacs’ broad Phase II program combining UV1